Evidence map›Paper›PMID 41719406›Full record

ArticleScience advances2026

Complement C3 recognition by C3 convertases.

Changhao Jia, Xiaoke Yang, Ming-Hui Zhao, Ying Tan, Junyu Xiao

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Changhao JiaRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China.ORCID 0009-0006-5667-5519
Xiaoke YangState Key Laboratory of Gene Function and Modulation Research, Biomedical Pioneering Innovation Center, School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Beijing Key Laboratory of Clinical Evaluation of Cardiovascular-Kidney-Metabolic and Immuno-Inflammatory Innovative Drugs and Medical Devices, Peking University, Beijing, P.R. China.ORCID 0009-0001-2106-0972
Ming-Hui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China.ORCID 0000-0003-3340-3108
Ying TanRenal Division, Department of Medicine, Peking University First Hospital, Beijing, P.R. China.ORCID 0000-0002-8139-5758
Junyu XiaoState Key Laboratory of Gene Function and Modulation Research, Biomedical Pioneering Innovation Center, School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Beijing Key Laboratory of Clinical Evaluation of Cardiovascular-Kidney-Metabolic and Immuno-Inflammatory Innovative Drugs and Medical Devices, Peking University, Beijing, P.R. China.ORCID 0000-0003-1822-1701

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complement system plays a fundamental role in immunity, and its dysregulation is implicated in numerous human diseases. Activation of complement occurs through three main pathways: classical, lectin, and alternative; which converge at the central component, component of complement 3 (C3). The classical and lectin pathways use the C4b2a convertase to cleave C3 and initiate complement activation, while the alternative pathway uses the C3bBb convertase, which is further stabilized by properdin. The molecular mechanisms governing C3 recognition by these convertase complexes remain incompletely understood. Here, we present the 3.1-angstrom cryo-electron microscopy structure of the C4b2a-C3 Michaelis complex, alongside 2.9- and 3.1-angstrom structures of the C4b2 zymogen in loading and activation states, elucidating the structural basis for C3 engagement by C4b2a and conformational changes during the classical and lectin pathway convertase maturation. Furthermore, a 2.6-angstrom structure of C3bBb-properdin in complex with C3 uncovers unique substrate-binding features of C3bBb and properdin's stabilizing role in the alternative pathway. These results offer comprehensive mechanistic insights into complement activation.

Indexed as

Complement C3Complement C3-C5 ConvertasesComplement ActivationCryoelectron MicroscopyHumansModels, MolecularProperdinProtein BindingProtein ConformationComplement C3Complement C3-C5 ConvertasesProperdin

Identifiers

PMID41719406
PMCPMC12922740

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.